TrilliumBiO
TrilliumBiO creates diagnostic tests that help clinicians make better treatment decisions. It develops and commercializes validated, physician-guided diagnostics through collaborations with healthcare innovators, supported by research partnerships and evidence-based development. The company leverages platforms in next-generation sequencing, chemistry, immunology, molecular diagnostics, AI algorithms, and tissue pathology to deliver customized, scalable solutions. Its business model centers on services, collaborations, and diagnostic solutions that integrate with clinical workflows. The approach targets healthcare providers and researchers to accelerate drug development, disease monitoring, and biomarker-driven adoption.
TrilliumBiO
TrilliumBiO creates diagnostic tests that help clinicians make better treatment decisions. It develops and commercializes validated, physician-guided diagnostics through collaborations with healthcare innovators, supported by research partnerships and evidence-based development. The company leverages platforms in next-generation sequencing, chemistry, immunology, molecular diagnostics, AI algorithms, and tissue pathology to deliver customized, scalable solutions. Its business model centers on services, collaborations, and diagnostic solutions that integrate with clinical workflows. The approach targets healthcare providers and researchers to accelerate drug development, disease monitoring, and biomarker-driven adoption.